Getting latest data loading
X

Request a Call to Trade

In addition to the daily Research emails, I would also like to receive the Accendo Markets Weekly Newsletter and occasional Market Report emails highlighting various trading opportunities.
When you enter your telephone number, we may call or message you occasionally with trading opportunities. You can opt out at any time
Home / Upgrades / Downgrades / Upgrades / Downgrades

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Upgrades/Downgrades - 5 December 2017

This page refreshes automatically every 30 mins. Press F5 to update manually

For a more detailed explanation of Upgrades/Downgrades see Link

Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained

Stock Ticker Broker New Rating Action Yday’s Close (p) Target (p) Action Distance to Target
Upgrades
Kingfisher KGF Morningstar Hold 330.6
Capital & Counties Properties CAPC Peel Hunt Reduce 260.9 250 -4%
Galliford Try GFRD Canaccord Genuity Buy 1188 1450
Morrison (Wm) Supermarkets MRW Goldman Sachs Neutral 214 210 -2%
Oxford Biomedica OXB N+1 Singer Buy 8.95 10.2 14%
Pendragon PDG Arden Partners Buy New 26
Persimmon PSN Canaccord Genuity Buy 2566 2870 12%
Rio Tinto RIO Morningstar Hold 3540
Spectris SXS Numis Reduce 2450 2100 -14%
Standard Chartered STAN JP Morgan Overweight 727.2 900 24%
Taylor Wimpey TW. Canaccord Genuity Buy 196.3 230 17%
Tesco TSCO Goldman Sachs Buy 195.15 220 13%
TI Fluid Systems TIFS Goldman Sachs Buy New 261.75 323 New 23%
TT Electronics TTG Stifel Buy New 225.5 280 New 24%
Unite UTG Peel Hunt Buy 726.5 725 0%
Downgrades
Booker BOK Goldman Sachs Neutral 219.2 215 -2%
Cineworld CINE Peel Hunt Hold 546 600 10%
Consort Medical CSRT N+1 Singer Hold 1160 1164 0%
Fenner FENR Numis Hold 390.75 400 2%
IMI IMI Numis Reduce 1279 1125 -12%
Renishaw RSW Numis Hold 5165 5200 1%
Spirax-Sarco Engineering SPX Numis Hold 5700 6000 5%

Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires

Back to Top

T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.

Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.